On August 12, the Food and Drug Administration (FDA) published an announcement amending the emergency use authorizations (EUAs) for the Pfizer-BioNTech COVID-19 Vaccine and the Moderna COVID-19 Vaccine to allow for an additional vaccine dose to certain moderately to severely immunocompromised individuals. The Centers for Disease Control and Prevention Services (CDC) recommends that certain immunocompromised individuals receive …

Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals Other fully vaccinated individuals do not need an additional vaccine dose right now Read More »